LQDA
Liquidia CorporationNASDAQHealthcare$37.68-0.08%ClosedMarket Cap: $3.32B
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
73.29
P/S
20.95
EV/EBITDA
-74.06
DCF Value
$-98.68
FCF Yield
-1.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
97.2%
Operating Margin
-32.5%
Net Margin
-43.5%
ROE
-209.3%
ROA
-21.0%
ROIC
-20.5%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $92.0M | 101.7% | $19.8M | $14.6M | $0.15 | — |
| FY 2025 | $158.3M | 97.2% | $-51.4M | $-68.9M | $-0.80 | — |
| Q3 2025 | $54.3M | 94.2% | $1.8M | $-3.5M | $-0.04 | — |
| Q2 2025 | $8.8M | 85.4% | $-37.5M | $-41.6M | $-0.49 | — |
| Q1 2025 | $3.1M | 51.4% | $-35.4M | $-38.4M | $-0.45 | — |
| Q4 2024 | $2.9M | 53.6% | $-36.1M | $-38.4M | $-0.45 | — |
| FY 2024 | $14.0M | 58.0% | $-121.3M | $-130.4M | $-1.66 | — |
| Q3 2024 | $4.4M | 64.8% | $-29.2M | $-23.2M | $-0.30 | — |
| Q2 2024 | $3.7M | 59.2% | $-27.2M | $-27.9M | $-0.37 | — |
| Q1 2024 | $3.0M | 40.9% | $-28.8M | $-40.9M | $-0.54 | — |
| Q4 2023 | $4.5M | 78.1% | $-26.4M | $-27.4M | $-0.42 | — |
| FY 2023 | $17.5M | 83.5% | $-73.4M | $-78.5M | $-1.21 | — |